Galderma Announces Publication of Pivotal Phase 3 PERFECT 1 and PERFECT 2 Clinical Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne in the Journal of the American Academy of Dermatology Press release
Galderma: New data reveals benefits of combining oral and topical treatment in patients with severe papulopustular rosacea Press release